FDA Pill Review Sparks Abortion Ban Fight

0:00Anti-abortion activists are getting heated with the Trump administration for dragging its feet on cracking down on abortion pills sent through the mail and prescribed online. They say its watering down stayed bands after Ro got overturned. This week, a federal judge in Louisiana cited with the state saying their lawsuit against the FDA has real merit, but he didn't stop telehealth. Prescriptions for my Fed pre-stone, right away. The FDA loosened rules on the pill during COVID, dropping in-person visits and letting it ship nationwide, based on years of safety data. Now, with 13 states banning abortions outright, officials argue online access keeps the procedures happening anyway. Surveys show US abortions haven't dropped since the 2022 Supreme Court decision. Frustration is boiling over among groups like students for life, who call the delay-stall tactics and want quicker restrictions, maybe even using an old law to block mailing. Some leaders praise Louisiana's attorney general for appealing to the 5th Circuit Court, worried

1:03it could hurt Republican turnout if the base feels, ignored heading into midterms. The FDA insists it's actively reviewing MIFF for stone safety, gathering data and planning peer reviews with a court order to report back in six months. Meanwhile, shield laws and blue states protect dock shipping pills to ban states, sparking more lawsuits. As the pills heat up and reviews drag on, this fight over pills could reshape how state bands hold up, testing the Post-Roll landscape right before. Election season hits full swing. This has been Canada News Today, powered by AI. I'm Cory with the story.